← Eichor
Study identifier: NCT05431738 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

Condition: Stent Migration · GastroEsophageal Cancer  ·  Sponsor: Société Française d'Endoscopie Digestive

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to 91 Years
Healthy volunteersNo

About this study

The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.

This description comes directly from the study's public registry record.

Talk to the study team

David KARSENTI, MD  ·  +33603454293  ·  karsenti@club-internet.fr

Always discuss trial participation with your own doctor first.

Locations (1)

French Society of Digestive EndoscopyParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05431738